No Data
Tokio Marine Holdings, Inc. (TKOMY) Q2 2024 Earnings Call Transcript Summary
Expanding while keeping an eye on the movements of the USA market.
The Nikkei index rebounded for the first time in three days, closing at 38,283.85 yen, up 257.68 yen (with an estimated volume of 1.6 billion 80 million shares). Following the rebound of nvidia in the previous day's usa market, more stocks rose in the Tokyo market, particularly in the semiconductors sector. Additionally, buying aimed at a self-rebound in response to the previous day's declines contributed to the rise, and the Nikkei index increased to 38,420.63 yen towards the end of the morning session. However, there are movements to adjust positions ahead of the weekend, and investors want to assess the situation in Russia and Ukraine.
Asahi Kogyo Co., Ltd. is updating its high for the year [stocks with new highs and lows].
The stocks that updated new highs on the main board are Obayashi Corporation <1802> and Asahi Kogyo <1975> among 27 stocks. The stocks that updated new lows on the main board are Askul <2678> and Create SD Holdings <3148> among 12 stocks. "Main Board" "Standard" "Growth" New highs New lows New highs New lows New highs New lows 11/22 271218101491 11/21 342223138811 11/20 292823141061 11/19.
Kaijom and others continue to rank, with ongoing license agreements with Asahi Kasei Pharma serving as a clue.
Kaiom <4583> has ranked (as of 14:32). It has significantly continued to rise. After the market closed on the 20th, the company announced that it had signed an exclusive licensing agreement with Asahi Kasei Pharma for its therapeutic antibody "Humanized Anti-CX3CR1 Antibody (PFKR)," leading to a stop high yesterday. Today, the buy star continues. In addition to receiving a one-time contract fee of 0.2 billion yen, Kaiom will receive milestone payments of up to approximately 24.8 billion yen depending on the future progress of development and sales. Furthermore, after the product launch, the company will receive...
Toyo Tanso---Continues to decline, with observations of multiple investment ratings being downgraded.
Decline continues. Daiwa Securities has downgraded the investment rating from "2" to "3" and also lowered the target stock price from 6,500 yen to 5,000 yen. Additionally, SMBC Nikko Securities has downgraded the investment rating from "1" to "2" and reduced the target stock price from 7,000 yen to 5,500 yen. It seems they are anticipating a slowdown in the growth of SiC-related products due to the deceleration of EV demand. They expect a valuation adjustment due to the retreat of short-term growth expectations.
Maruha Nichiro, Chugai Pharmaceutical, etc. (additional) Rating
Upgrades - bullish Code Stock Name Securities Company Previous Change After ------------------------------------------------------- <1802>Obayashi Corporation SMBC Nikko "2" "1" <1808>Haseko Corporation SMBC Nikko "2" "1" Downgrades - bearish Code Stock Name Securities Company Previous Change After ------------------------------------------------------- <3382>